Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Acute Pyelonephritis I: Introduction

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based study.

European journal of cancer (Oxford, England : 1990)·2025

Same author

Ultrasound assessment of Achilles enthesitis: a dedicated training program.

Reumatismo·2024

Same author

Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030.

ESMO open·2024

Same author

Novelties in slipped capital femoral epiphysis imaging: A narrative review.

Heliyon·2024

Same author

Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes.

Journal of endocrinological investigation·2024

Same author

Nailfold capillaroscopy in the rheumatological current clinical practice in Italy: results of a national survey.

Reumatismo·2022

Search research articles

Related Experiment Video

Updated: May 25, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Clinical features of gout.

W Grassi¹, R De Angelis

¹Clinica Reumatologica, Università Politecnica delle Marche, Ancona, Italy. walter.grassi@univpm.it

|February 4, 2012

Summary

Gout is a metabolic disease caused by monosodium urate (MSU) crystal deposition, leading to acute flares and chronic changes. Diagnosis relies on identifying MSU crystals in joint fluid.

Area of Science:

Rheumatology
Metabolic Diseases
Crystal-Induced Arthropathies

Background:

Gout is a metabolic disorder defined by hyperuricemia and monosodium urate (MSU) crystal deposition in joints and soft tissues.
It presents with acute, self-limited synovitis attacks and a chronic phase marked by inflammatory and structural joint damage.
Acute gout attacks typically involve sudden, intense monoarthritis, often affecting the big toe, and can also impact periarticular structures.

Purpose of the Study:

To provide a comprehensive overview of gout, encompassing its pathophysiology, clinical presentation, diagnostic criteria, and associated comorbidities.
To highlight the diagnostic significance of monosodium urate crystals in synovial fluid.
To discuss the progression from acute flares to chronic gout and its systemic implications.

More Related Videos

Synovial Fluid Analysis to Identify Osteoarthritis

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

Related Experiment Videos

Last Updated: May 25, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Synovial Fluid Analysis to Identify Osteoarthritis

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

Main Methods:

Review of existing literature on gout pathophysiology and clinical manifestations.
Analysis of diagnostic criteria, emphasizing polarized microscopy for MSU crystal identification.
Examination of the relationship between hyperuricemia, MSU deposition, and chronic complications.

Main Results:

Monosodium urate (MSU) crystals in joint fluid, identified as needle-like with negative birefringence, are crucial for gout diagnosis.
Gout involves distinct acute phases (synovitis) and chronic phases with MSU crystal aggregation (tophi) in various tissues.
Chronic gout is associated with significant comorbidities, including metabolic syndrome, kidney disease, and cardiovascular issues, impacting quality of life.

Conclusions:

Gout is a complex metabolic disease requiring accurate diagnosis through MSU crystal identification.
Effective management of hyperuricemia is essential to prevent acute flares and the progression to chronic gout and its associated complications.
The strong link between gout, metabolic syndrome, and cardiovascular disease underscores the need for a holistic patient management approach.